Table 1 Patient characteristics
From: Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study
Patient number, n | 2101 |
|---|---|
Age, year | 55.42 ± 15.27 |
Gender, n (%) | |
Male | 606 (28.84) |
Female | 1495 (71.16) |
Age, year | |
< 45 | 508 (24.18) |
≥ 45 | 1593 (75.82) |
Race, n (%) | |
White | 1736 (82.63) |
Black | 188 (8.95) |
American Indian/Alaska Native, Asian/Pacific Islander | 144 (6.85) |
Unknown | 33 (1.57) |
SEER stagea, n (%) | |
Local | 1740 (82.82) |
Regional | 245 (11.66) |
Distant | 89 (4.24) |
Unspecified | 27 (1.28) |
Lymph node examination, n (%) | |
Not examined | 1406 (66.92) |
Negative | 574 (27.32) |
Positive | 92 (4.38) |
Unspecified | 29 (1.38) |
Tumor grade, n (%) | |
Well differentiated | 282 (13.42) |
Moderately differentiated | 80 (3.81) |
Poorly differentiated | 41 (1.95) |
Undifferentiated | 13 (0.62) |
Unspecified | 1685 (80.20) |
Tumor multifocalityb, n (%) | |
No | 1657 (78.87) |
Yes | 352 (16.75) |
Unspecified | 92 (4.38) |
Tumor extension, n (%) | |
Intrathyroidal | 1768 (84.15) |
Extrathyroidal | 301 (14.33) |
Unspecified | 32 (1.52) |
T-stage, n (%) | |
T1 | 486 (23.13) |
T2 | 707 (33.65) |
T3 | 708 (33.70) |
T4 | 98 (4.66) |
Unspecified | 102 (4.85) |
N-stage, n (%) | |
N0 | 1913 (91.05) |
N1 | 113 (5.38) |
Unspecified | 75 (3.57) |
M-stage, n (%) | |
M0 | 1995 (94.95) |
M1 | 59 (2.81) |
Unspecified | 47 (2.24) |
Surgery, n (%) | |
No | 29 (1.38) |
Total thyroidectomy | 1669 (79.44) |
Partial thyroidectomy | 382 (18.18) |
Unspecified | 21 (0.99) |
Radiotherapy, n (%) | |
No | 850 (40.46) |
Radioactive iodine | 1155 (54.97) |
Unspecified | 96 (4.57) |